MRI could help detect Alzheimer’s disease at an early stage - before irreversible damage has been done, according to the second recent study to examine MRI use for Alzheimer’s.
MRI could help detect Alzheimer’s disease at an early stage - before irreversible damage has been done, according to the second recent study to examine MRI use for Alzheimer’s.
For this study, published online and in the June edition of Radiology, researchers looked at elderly people with normal cognitive ability to see if automated brain volume measurements on MRI could predict future memory decline.
“One of the things that made our study novel was that we looked at patients who were cognitively normal at baseline, rather than people with mild cognitive impairment,” said lead author Gloria C. Chiang, MD, radiology resident at University of California San Francisco.
Researchers assessed 149 participants with an initial baseline MRI scan and a neuropsychological assessment. Follow-up exams two years later showed that 25 of the participants, 17 percent, had memory decline.
The study looked at volume changes across several regions of the temporal and parietal lobes, unlike previous research that has looked mainly at the medial temporal lobe of the brain.
According to researchers, the predictive accuracy of the classification model increased with the exapanded number of brain regions included in the model. Models examining several areas of both lobes had an 81 percent accuracy rate when it comes to distinguishing between cognitively normal people and those without memory decline.
“Our study showed that volume loss in multiple regions that may be interconnected had a greater impact on memory decline. We found that automated temporal and parietal volumes identified those at risk for future memory decline with high accuracy,” Chiang said in a statement.
Another study in the June issue examined how using MRI may help researchers predict which adults are likely to develop Alzheimer’s disease.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
Could Ultrafast MRI Enhance Detection of Malignant Foci for Breast Cancer?
April 10th 2025In a new study involving over 120 women, nearly two-thirds of whom had a family history of breast cancer, ultrafast MRI findings revealed a 5 percent increase in malignancy risk for each second increase in the difference between lesion and background parenchymal enhancement (BPE) time to enhancement (TTE).